Home › Funds › Glaxis Capital Management, LLC › ABBV
Glaxis Capital Management, LLC position in ABBV
ABBVIE INC · Health Care
Glaxis Capital Management, LLC reported holding 5,000 shares of ABBV (ABBVIE INC) in its Q2 2026 13F filing — a position valued at US$1.3M, representing 2.53% of its reported portfolio and ranking #13 among its reported holdings. Glaxis Capital Management, LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Glaxis Capital Management, LLC's ABBV position evolved
Glaxis Capital Management, LLC first disclosed a stake in ABBV in Q2 2026 at 5,000 shares (US$1.3M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 5.00K | $1.26M | New |
About ABBV and 13F data
ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABBV
- Vanguard Group 180.78M sh · $41.31B · Q4 2025
- BlackRock Inc 149.49M sh · $37.62B · Q2 2026
- VANGUARD CAPITAL MANAGEMENT LLC 115.40M sh · $29.04B · Q2 2026
- Banque Cantonale Vaudoise 89.31K sh · $22.47B · Q2 2026
- STATE STREET CORP 81.22M sh · $17.66B · Q1 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 48.48M sh · $12.20B · Q2 2026
- GEODE CAPITAL MANAGEMENT, LLC 47.00M sh · $11.81B · Q2 2026
- Geode Capital Management 47.00M sh · $11.81B · Q2 2026
- Morgan Stanley 38.90M sh · $9.79B · Q2 2026
- Capital Research Global Investors 30.10M sh · $7.57B · Q2 2026
- Capital Research Global Investors 30.10M sh · $7.57B · Q2 2026
- Norges Bank Investment Management 25.55M sh · $6.43B · Q2 2026
More on Glaxis Capital Management, LLC
FAQ
How long has Glaxis Capital Management, LLC held ABBV?
Glaxis Capital Management, LLC has disclosed ABBV holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Glaxis Capital Management, LLC's current position in ABBV?
As of Q2 2026, Glaxis Capital Management, LLC holds 5.00K shares of ABBV (ABBVIE INC), valued at $1.26M, representing 2.53% of its reported portfolio and ranking #13.
Has Glaxis Capital Management, LLC been buying or selling ABBV?
In the latest 13F filing (Q2 2026), Glaxis Capital Management, LLC newly opened its position in ABBV.
Which other funds hold ABBV?
Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.